期刊文献+

PPARδ激动剂GW501516抑制ox-LDL或高糖诱导的人脐静脉内皮细胞凋亡 被引量:3

PPARδ agonist GW501516 inhibits ox-LDL-or high glucose-induced apoptosis in human umbilical vein endothelial cells
在线阅读 下载PDF
导出
摘要 目的:探讨过氧化物酶体增殖物激活受体δ(PPARδ)激动剂GW501516对氧化低密度脂蛋白(ox-LDL)和高糖诱导的人脐静脉内皮细胞(HUVECs)凋亡的抑制作用。方法:ox-LDL或高糖诱发HUVECs凋亡,给予不同浓度GW501516处理后,用流式细胞术检测细胞凋亡率的变化。采用MTT法检测ox-LDL或高糖对HU-VECs生长活性的影响,用不同浓度GW501516干预后观察细胞生长活性的变化。结果:ox-LDL诱导的细胞凋亡率是21.30%,不同浓度GW501516处理组凋亡率分别为17.47%、9.72%和3.94%,高糖诱导的细胞凋亡率为22.65%,不同浓度GW501516处理组凋亡率分别为20.23%、17.01%和9.38%,结果显示GW501516可抑制ox-LDL或高糖诱导的细胞凋亡,且呈剂量依赖性;MTT结果显示,GW501516可使ox-LDL或高糖对HUVECs活性的抑制作用减弱。结论:GW501516可抑制ox-LDL或高糖诱导的HUVECs凋亡;并减弱ox-LDL或高糖对HU-VECs活性的抑制作用。 AIM: To investigate the inhibitory effect of peroxisome proliferator-activated receptor δ(PPARδ) agonist GW501516 on the apoptosis induced by oxidized low-density lipoprotein(ox-LDL) or high concentration of glucose in human umbilical vein endothelial cells(HUVECs). METHODS: Cell apoptosis was induced by ox-LDL or high concentration of glucose in HUVECs and was examined by flow cytometry.The HUVECs were treated with GW501516 at different concentrations.The viability of HUVECs was analyzed by MTT assay. RESULTS: The apoptosis rate of HUVECs treated with ox-LDL was 21.3%,while those of HUVECs treated with ox-LDL combined with low,medium and high concentrations of GW501516 were 17.47%,9.72% and 3.94%,respectively.The apoptosis rate of HUVECs treated with glucose was 22.60%,while those of HUVECs treated with glucose combined with different concentrations of GW501516 were 20.23%,17.01% and 9.38%,respectively.The results indicated that ox-LDL or glucose induced apoptosis of HUVECs and GW501516 decreased the apoptotic rates induced by ox-LDL or glucose in a dose-dependent manner.The results of MTT assay showed that glucose or ox-LDL decreased the viability of HUVECs and GW501516 attenuated the effect of glucose or ox-LDL on HUVECs. CONCLUSION: GW501516 inhibits the apoptotic effects of ox-LDL and glucose on HUVECs and increases the viability of the cells.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第11期2077-2081,共5页 Chinese Journal of Pathophysiology
基金 内蒙古医学院青年基金资助项目(No.NY2006QN007)
关键词 过氧化物酶体增殖物激活受体Δ GW501516 人脐静脉内皮细胞 细胞凋亡 Peroxisome proliferator-activated receptor δ GW501516 Human umbilical vein endothelial cells Apoptosis
  • 相关文献

参考文献14

  • 1Sznaidman ML,Haffner CD,Maloney PR,et al.Novel selective small molecule agonists for peroxisome proliferator -activated receptor δ (PPARδ)-synthesis and biological activity[J].Bioorg Med Chem Lett,2003,13 (9):1517-1521.
  • 2Sprecher DL,Massien C,Pearce G,et al.Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist[J].Arterioscler Thromb Vasc Biol,2007,27(2):359-365.
  • 3Wang YX,Lee CH,Tiep S,et al.Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity[J].Cell,2003,113(2):159-170.
  • 4Lee CH,Chawla A,Urbiztondo N,et al.Transcriptional repression of atherogenic inflammation:modulation by PPARδ[J].Science,2003,302 (5644):453-457.
  • 5Herbert JM,Dupuy E,Laplace MC,et al.Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway[J].Biochem J,1994,303(Pt 1):227 -231.
  • 6Lee CH,Olson P,Hevener A,et al.PPARδ regulates glucose metabolism and insulin sensitivity[J].Proc Natl Acad Sci USA,2006,103(9):3444 -3449.
  • 7Hu C,Jia W,Fang Q,et al.Peroxisome proliferator-activated receptor (PPAR)delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects[J].Diabet Med,2006,23(12):1307-1312.
  • 8Bzrish GD,Atkins AR,Downes M,et al.PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis[J].Proc Natl Acad Sci USA,2008,105(11):4271-4276.
  • 9杨大春,马双陶,杨永健,李秀川,张继红,唐兵,李德.激活PPARδ对梗死心肌MMP-9及纤连蛋白表达的影响[J].中国病理生理杂志,2010,26(11):2130-2135. 被引量:5
  • 10Ho FM,Lin WW,Chen BC,et al.High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-κB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway[J].Cell Signal,2006,18(3):391-399.

二级参考文献17

  • 1杨永健,张鑫,朱文玲,黄艳.基质金属蛋白酶参与心力衰竭患者心肌细胞外基质的调控[J].中华医学杂志,2006,86(24):1693-1696. 被引量:13
  • 2杨永健,张鑫,杨大春.血管紧张素Ⅱ对肥厚心肌基质金属蛋白酶及细胞外基质的影响[J].中国病理生理杂志,2007,23(7):1277-1280. 被引量:5
  • 3Lindsey ML,Mann DL,Entman ML,et al.Extracellular matrix remodeling following myocardial injury[J].Ann Med,2003,35(5):316-326.
  • 4Schmidt R,Bultmann A,Ungerer M,et al.Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells:implications in acute myocardial infarction[J].Circulation,2006,113(6):834-841.
  • 5Yang D,Ma S,Li D,et al.Angiotensin Ⅱ receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium[J].Biochem Biophys Res Commun,2009,388(3):606-611.
  • 6Brown L.Cardiac extracellular matrix:a dynamic entity[J].Am J Physiol Heart Circ Physiol,2005,289(3):H973-H974.
  • 7Lee CH,Chawla A,Urbiztondo N,et al.Transcriptional repression of atherogenic inflammation:modulation by PPARδ[J].Science,2003,302(5644):453-457.
  • 8Chinetti G,Fruchart JC,Staels B.Peroxisome proliferator-activated receptors (PPARs):nuclear receptors at the crossroads between lipid metabolism and inflammation[J].Inflamm Res,2000,49(10):497-505.
  • 9Cheng L,Ding G,Qin Q,et al.Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy[J].Nat Med,2004,10(11):1245-1250.
  • 10Remppis A,Ehlermann P,Giannitsis E,et al.Cardiac troponin T levels at 96 hours reflect myocardial infarct size:a pathoanatomical study[J].Cardiology,2000,93 (4):249-253.

共引文献4

同被引文献36

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部